Dr Michael Mosley was a firm believer in intermittent fasting and has shared his tips on what to eat to ensure you get the ...

Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Carleara Weiss will study how nicotinamide riboside, a type of vitamin B3, affects sleep and memory in older adults.

Alzheimer's is generally characterised by memory loss and other cognitive abilities serious enough to interfere with daily ...

Nearly 7 million Americans have Alzheimer's disease, and this number is predicted to double by 2060. While aging and genetic predisposition are the most important risk factors for Alzheimer's, ...

Semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

In a breakthrough for digital therapeutics companies, under the 2025 Medicare rules, clinicians can bill for some mental health apps. Plus: Insurers fear losing out on millions; Medicaid counseling on ...

Staying active, eating healthier and considering medication can help manage hypertension and reduce dementia risk ...

The following is a summary of “Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes: Findings From ...

UB nursing professor Carleara Weiss will focus on the link among biomarkers of neurodegeneration, sleep disturbances and cognitive decline.